SCHEMBL30493732

SCHEMBL30493732

O=C1CCC(N2Cc3c(OCc4ccc(CN5CCN(S(=O)(=O)C(F)(F)F)CC5)cc4)cccc3C2=O)C(=O)N1

nearest known ligand 0.78

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 18/20 0.78
▸ IKZF3 Q9UKT9 18/20 0.78
▸ TNF P01375 3/20 0.73
▸ IL1B P01584 3/20 0.73
▸ DDB1 Q16531 3/20 0.73
▸ IKZF1 Q13422 1/20 0.73
▸ DRD2 P14416 1/20 0.69
▸ ADRA1D P25100 1/20 0.69
▸ ADRA1A P35348 1/20 0.69
▸ ADRA1B P35368 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12373208 1.00 CRBN (0.78) CRBNIKZF3TNFIL1BDDB1
SCHEMBL2248892 1.00 CRBN (0.78) CRBNIKZF3TNFIL1BDDB1
Hydrochloric Acid SCHEMBL2255798 0.99 CRBN (0.76) CRBNIKZF3TNFIL1BDDB1
SCHEMBL2250364 0.94 CRBN (0.68) CRBNIKZF3TNFIL1BDDB1
SCHEMBL30493802 0.91 CRBN (0.75) CRBNIKZF3TNFIL1BDDB1
SCHEMBL2252005 0.91 CRBN (0.75) CRBNIKZF3TNFIL1BDDB1
SCHEMBL26318062 0.90 CRBN (0.91) CRBNIKZF3TNFIL1BDDB1
SCHEMBL26321494 0.90 CRBN (0.91) CRBNIKZF3TNFIL1BDDB1
SCHEMBL2254498 0.90 CRBN (0.82) CRBNIKZF3TNFIL1BDDB1
SCHEMBL2248202 0.90 CRBN (0.82) CRBNIKZF3TNFIL1BDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289838-A2 ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME Celgene Corporation (US) 2023-12-13 — — EP disclosed
EP-3599236-B1 ARYLMETHOXY ISOINDOLINE DERIVATIVES AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME CELGENE CORP (US) 2023-08-23 — — EP disclosed
Send feedback